172 related articles for article (PubMed ID: 28009988)
1. A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.
Mao Y; Wang J; Zhang M; Fan W; Tang Q; Xiong S; Tang X; Xu J; Wang L; Yang S; Liu S; Xu L; Chen Y; Xu L; Yin R; Zhu J
Oncotarget; 2017 Feb; 8(7):10954-10965. PubMed ID: 28009988
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
Liu YP; Tan YN; Wang ZL; Zeng L; Lu ZX; Li LL; Luo W; Tang M; Cao Y
Int J Mol Med; 2008 Feb; 21(2):153-62. PubMed ID: 18204781
[TBL] [Abstract][Full Text] [Related]
3. STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling.
Wang Z; Luo F; Li L; Yang L; Hu D; Ma X; Lu Z; Sun L; Cao Y
Eur J Cancer; 2010 Nov; 46(16):2996-3006. PubMed ID: 20709526
[TBL] [Abstract][Full Text] [Related]
4. LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL).
Mao Y; Zhang DW; Zhu H; Lin H; Xiong L; Cao Q; Liu Y; Li QD; Xu JR; Xu LF; Chen RJ
Diagn Pathol; 2012 Dec; 7():178. PubMed ID: 23237707
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
6. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
[TBL] [Abstract][Full Text] [Related]
7. Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.
Wu T; Wang S; Wu J; Lin Z; Sui X; Xu X; Shimizu N; Chen B; Wang X
J Exp Clin Cancer Res; 2015 Feb; 34(1):17. PubMed ID: 25887673
[TBL] [Abstract][Full Text] [Related]
8. Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Sim SH; Kim S; Kim TM; Jeon YK; Nam SJ; Ahn YO; Keam B; Park HH; Kim DW; Kim CW; Heo DS
Am J Pathol; 2017 May; 187(5):980-986. PubMed ID: 28284718
[TBL] [Abstract][Full Text] [Related]
9. The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma.
Xu L; Qin Y; Liu M; Jiao J; Tu D; Zhang M; Yan D; Song X; Sun C; Zhu F; Wang X; Sang W; Xu K
Anticancer Agents Med Chem; 2022; 22(8):1530-1540. PubMed ID: 34503423
[TBL] [Abstract][Full Text] [Related]
10. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
Guo Y; Arakawa F; Miyoshi H; Niino D; Kawano R; Ohshima K
Pathol Int; 2014 Jun; 64(6):263-6. PubMed ID: 24965108
[TBL] [Abstract][Full Text] [Related]
11. HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial function and EBV suppression.
Chen Q; Feng J; Wu J; Yu Z; Zhang W; Chen Y; Yao P; Zhang H
Leukemia; 2020 Oct; 34(10):2736-2748. PubMed ID: 32203147
[TBL] [Abstract][Full Text] [Related]
12. Genotypic analysis and latent membrane protein 1 expression of Epstein-Barr virus in extranodal NK/T-cell lymphoma from Northern Chinese patients.
Wang H; Li H; Xing X; Zhao C; Luo B
Arch Virol; 2015 Aug; 160(8):2071-4. PubMed ID: 26008210
[TBL] [Abstract][Full Text] [Related]
13. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
[TBL] [Abstract][Full Text] [Related]
14. A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.
Kim BH; Yin CH; Guo Q; Bach EA; Lee H; Sandoval C; Jayabose S; Ulaczyk-Lesanko A; Hall DG; Baeg GH
Mol Cancer Ther; 2008 Sep; 7(9):2672-80. PubMed ID: 18790749
[TBL] [Abstract][Full Text] [Related]
15. ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell Lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT Pathway.
Yang H; Ma P; Cao Y; Zhang M; Li L; Wei J; Tao L; Qian K
Anticancer Agents Med Chem; 2018; 18(3):401-411. PubMed ID: 28356009
[TBL] [Abstract][Full Text] [Related]
16. The molecular mechanism of curcumol on inducing cell growth arrest and apoptosis in Jurkat cells, a model of CD4⁺ T cells.
Wang H; Wang Y; Jiang X; Wang Z; Zhong B; Fang Y
Int Immunopharmacol; 2014 Aug; 21(2):375-82. PubMed ID: 24877754
[TBL] [Abstract][Full Text] [Related]
17. Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.
Montes-Mojarro IA; Chen BJ; Ramirez-Ibarguen AF; Quezada-Fiallos CM; Pérez-Báez WB; Dueñas D; Casavilca-Zambrano S; Ortiz-Mayor M; Rojas-Bilbao E; García-Rivello H; Metrebian MF; Narbaitz M; Barrionuevo C; Lome-Maldonado C; Bonzheim I; Fend F; Steinhilber J; Quintanilla-Martinez L
Mod Pathol; 2020 May; 33(5):781-791. PubMed ID: 31822801
[TBL] [Abstract][Full Text] [Related]
18. Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.
Takahara M; Kis LL; Nagy N; Liu A; Harabuchi Y; Klein G; Klein E
Int J Cancer; 2006 Dec; 119(12):2775-83. PubMed ID: 17013900
[TBL] [Abstract][Full Text] [Related]
19. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.
Ishii H; Takahara M; Nagato T; Kis LL; Nagy N; Kishibe K; Harabuchi Y; Klein E
Int J Cancer; 2012 Jan; 130(1):48-58. PubMed ID: 21618217
[TBL] [Abstract][Full Text] [Related]
20. The JAK inhibitor antcin H exhibits direct anticancer activity while enhancing chemotherapy against LMP1-expressed lymphoma.
Chen YF; Chang CH; Huang ZN; Su YC; Chang SJ; Jan JS
Leuk Lymphoma; 2019 May; 60(5):1193-1203. PubMed ID: 30277103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
